Lisa Rambout
Overview
Explore the profile of Lisa Rambout including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
7
Citations
141
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Implementation of a Hepatitis B Screening Program in Patients Receiving Systemic Anti-Cancer Therapy
Leigh J, Mallick R, Brule S, Rambout L, Newton J, Bosse D, et al.
Curr Oncol
. 2025 Jan;
32(1).
PMID: 39851936
Cancer patients receiving non-endocrine therapies are at risk of hepatitis B virus (HBV) reactivation (HBVr). Guidelines recommend HBV screening prior to treatment. The Ottawa Hospital Cancer Center implemented a screening...
2.
Stacey D, Jolicoeur L, Balchin K, Duke K, Ludwig C, Carley M, et al.
Can Oncol Nurs J
. 2020 Oct;
30(3):200-207.
PMID: 33118987
No abstract available.
3.
Stacey D, Jolicoeur L, Balchin K, Duke K, Ludwig C, Carley M, et al.
Can Oncol Nurs J
. 2020 Oct;
30(3):193-199.
PMID: 33118979
A quality improvement project was conducted to determine the quality of telephone nursing for patients with cancer symptoms. Eligible patients were ones who telephoned the nurse about cancer symptom(s) within...
4.
Stacey D, Ludwig C, Jolicoeur L, Carley M, Balchin K, Jibb L, et al.
Support Care Cancer
. 2020 Jun;
29(2):841-849.
PMID: 32495032
Purpose: To determine the quality of cancer symptom management when evidence from clinical practice guidelines are used in telephone-based oncology nursing services. Methods: Guided by the Knowledge to Action Framework,...
5.
Rambout L, Tashkandi M, Hopkins L, Tricco A
Prev Med
. 2013 Nov;
58:22-32.
PMID: 24176938
Objective: Widespread uptake of preventive human papillomavirus vaccination among target groups is an important public health goal. To evaluate barriers and facilitators to human papillomavirus vaccination, we conducted a systematic...
6.
Hopkins L, Carrier M, Plante M, Luna V, Gotlieb W, Rambout L
J Obstet Gynaecol Can
. 2012 Jun;
34(7):673-7.
PMID: 22742487
Objective: Venous thromboembolism (VTE) is a significant cause of morbidity and mortality following gynaecologic cancer surgery. The objective of this study was to assess the current practice for VTE prophylaxis...
7.
8.
Rambout L, Hopkins L, Hutton B, Fergusson D
CMAJ
. 2007 Aug;
177(5):469-79.
PMID: 17671238
Background: Human papillomavirus (HPV) is now known to be a necessary cause of cervical cancer, and prophylactic HPV vaccines aimed at preventing genital warts, precancerous cervical lesions and cervical cancer...